TABLE 1.
Antimicrobial susceptibility of MRSA strains in this study
Antimicrobial agenta | MIC (μg/ml) for strains isolated from patients:
|
|||||
---|---|---|---|---|---|---|
With impetigo and SSSS
|
Without impetigo and SSSS
|
|||||
Range | 50% | 90% | Range | 50% | 90% | |
Oxacillin | 4-≥256 | 64 | 128 | 4-≥256 | ≥256 | ≥256 |
Cefmetazole | 4-≥64 | 32 | ≥64 | 4-≥64 | ≥64 | ≥64 |
Clarithromycin | ≤0.125-≥256 | ≥256 | ≥256 | ≤0.125-≥256 | ≥256 | ≥256 |
Levofloxacin | ≤0.125-≥256 | ≤0.125 | ≤0.125 | ≤0.125-≥256 | ≥256 | ≥256 |
Gentamicin | 0.5-≥64 | ≥64 | ≥64 | 0.25-≥64 | ≥64 | ≥64 |
Arbekacin | 0.5-8 | 2 | 4 | 0.25-≥32 | 1 | 2 |
Vancomycin | ≤0.5-2 | 1 | 1 | ≤0.5-2 | 1 | 1 |
Minocycline | ≤0.125-16 | ≤0.125 | 0.25 | ≤0.125-32 | 16 | 16 |
Benzalkonium-Cl | 2-4 | 2 | 2 | 1-8 | 4 | 8 |
Benzethonium-Cl | 1-8 | 1 | 2 | 0.5-16 | 4 | 8 |
Chlorhexidine-Glu | 1-4 | 2 | 2 | 1-8 | 4 | 4 |
Cetyltrimethylammonium-Br | ≤0.5-16 | 4 | 8 | 2-16 | 8 | 8 |
Ethidium-Br | 1-32 | 8 | 8 | 1-≥256 | 8 | ≥256 |
Benzalkonium-Cl, benzalkonium chloride; benzethonium-Cl, benzethonium chloride; chlorhexidine-Glu, chlorhexidine digluconate; cetyltrimethylammonium-Br, cetyltrimethylammonium bromide; ethidium-Br, ethidium bromide.